Lincomycin

INDICATIONS

FDA

  • Treatment of serious infections caused by susceptible strains of streptococci, pneumococci, and staphylococci in PCN-allergic patients.
  • Only IV formulation is available in U.S.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: March 4, 2018